Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
OVX-836 by Osivax for Unspecified Influenza Virus Infections: Likelihood of Approval
OVX-836 is under clinical development by Osivax and currently in Phase II for Unspecified Influenza Virus Infections. According to GlobalData,...